Search - tctmd.com

Displaying 81 - 90 of 90

Sort: Relevancy | Date

Presentation TCT 2018

Use of ECMO during Cardiac Arrest: When and How, Complications and Outcomes

Presenter: Cindy L. Grines, E. Magnus Ohman, Sachin Kumar

September 22, 2018

Presentation TCT 2017

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

Presenter: Vladimir Dzavik, Navin K. Kapur, Christian M. Spaulding

October 31, 2017

News Daily News

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

Shelley Wood

September 21, 2017

News Daily News

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Caitlin E. Cox

April 28, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

February 04, 2016

News Daily News

Upswing Seen in Pulmonary Artery Catheter Use in Acute Heart Failure

Todd Neale

December 06, 2015

News Industry News

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

August 31, 2015

News Industry News

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

August 26, 2015

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

News Daily News

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

Jason Kahn

June 06, 2011

Advertisement

Use of ECMO during Cardiac Arrest: When and How, Complications and Outcomes

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research

Cardiac Intensive Care Units Face an Ever More Complex Patient Population

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

Upswing Seen in Pulmonary Artery Catheter Use in Acute Heart Failure

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

Small Heart Failure Studies Show Positive Trends for Cell Therapy

CABG Plus Stem Cells Equals Improved LV Function in MI Patients with Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content